Cancer The Effects of Combined Drug Therapy in the Treatment of BRAF Mutated MelanomaReplication Stress-Activated DNA Damage Response Enhances the Radioresistance of Glioblastoma Stem CellsThe Role of p53 Target p21 and Nuclear Factor-κb Modulating Cellular Senescence in Hepatic FibrosisThe Implications of Differences in Spatial Distribution of LGR5 in Colorectal Cancer Adenomas as an Indication of Variations in Wnt Pathway Signaling AmountMechanisms of DNA Damage in Breast Cancer and Inhibition of DNA Repair through PARP InhibitorsThe Role of Inflammatory Response Element CTBP1 in Metabolic Syndrome and Prostate Cancer MetastasisMiR-34a Suppresses p53-Mediated Tumorigenesis and Epithelial-Mesenchymal Transition in Non-Small Cell Lung CancerPARP Inhibitor as Adjuvant Therapy for GlioblastomaTherapeutic Paradigms That Target Glioblastoma Multiform (GBM) Tumor Metabolism and Available Substrates for Glycolysis in the Tumor Microenvironments (TME)Decreased miR-122 Leads to Multi-Drug Resistance in Hepatocellular Cancer